A model workflow for microfluidic enrichment and genetic analysis of circulating melanoma cells

C Cristina Poggiana A Alessandro Francesco Piazza C Cristina Catoni I Ilaria Gallingani L Luisa Piccin S Stefania Pellegrini V Vittorio Aneloni V Valentina Salizzato J Jacopo Pigozzo A Alessio Fabozzi A Antonella Facchinetti C Chiara Menin P Paolo del Fiore S Simone Mocellin V Vanna Chiarion-Sileni (From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) — both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) — all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology–Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases–West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen — all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Brist...) A Antonio Rosato M Maria Chiara Scaini

Article Details

Volume / Issue Vol. 15, Issue 1
Published May 02, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (17)

C

Cristina Poggiana

A

Alessandro Francesco Piazza

C

Cristina Catoni

I

Ilaria Gallingani

L

Luisa Piccin

S

Stefania Pellegrini

V

Vittorio Aneloni

V

Valentina Salizzato

J

Jacopo Pigozzo

A

Alessio Fabozzi

A

Antonella Facchinetti

C

Chiara Menin

P

Paolo del Fiore

S

Simone Mocellin

V

Vanna Chiarion-Sileni

From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) — both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) — all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology–Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases–West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen — all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Brist...

A

Antonio Rosato

M

Maria Chiara Scaini